Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-85.94	8.70	-61.83
Graham Fair Price	41.44	2.20	1.56
PEG	142.67	< 0.005	< 0.005
Price/Book	-16.67	0.34	0.41
Price/Cash Flow	-16.69	-17.25	20.70
Prices/Earnings	-58.34	0.54	1.30
Price/Sales	-58.33	0.03	0.06
Price/FCF	-16.69	-17.25	20.70
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-60.42	< 0.005	0.01
Operating Margin	-95.73	< 0.005	-0.01
ROA	100.00	0.05	0.03
ROE	0.08	0.16	100.00
ROIC	-0.04	< 0.005	-91.50
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	< 0.005	-0.20	-95.73
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-7.25	1.09	-85.03
EPS QOQ	5.57	0.96	-82.83
FCF QOQ	16.21	-2.00	-87.66
Revenue QOQ	-0.29	1.00	244.36
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	4.23	2.10	-50.39
Days Sales Outstanding (DSO)	11.22	5.73	-48.98
Inventory Turnover	21.26	42.85	101.59
Debt/Capitalization	0.42	0.42	0.48
Quick Ratio	0.60	0.61	1.64
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	1.17	1.17	< 0.005
Cash	0.21	0.21	< 0.005
Capex	-0.08	-0.17	-100.02
Free Cash Flow	0.02	-0.02	0.03
Revenue	7.40	14.79	99.96
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.79	0.79	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-35.49	5.40	-84.80
Naive Interpretation	Member

06 - Financial Health · Bad

Rating